Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study - Owen, C; Ngian, G S; Elford, K (Clin Exp Rheumatol, 2016)
(5, Suppl 100):